TB prevention activities in the WHO European Region.

A Matteelli, Z Mkrtchyan, T Masini, A Hovhannesyan, G Kuchukhidze, S Ahmedov, P Kerndt, L Rossi, A Yedilbayev, D Falzon, A Dadu
{"title":"TB prevention activities in the WHO European Region.","authors":"A Matteelli, Z Mkrtchyan, T Masini, A Hovhannesyan, G Kuchukhidze, S Ahmedov, P Kerndt, L Rossi, A Yedilbayev, D Falzon, A Dadu","doi":"10.5588/ijtldopen.24.0350","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>TB preventive treatment (TPT) is the primary available healthcare intervention to reduce the risk of progression from TB infection to TB disease. The WHO Regional Office for Europe established the European Prevention and Systematic Screening Initiative to End TB (PASS) to scale up activities related to the programmatic management of TPT. In the absence of a system to measure and monitor preventive activities, a baseline assessment survey was carried out to provide a reference to monitor the scale-up of the intervention.</p><p><strong>Methods: </strong>This was a semi-structured survey including 52 questions that was developed, implemented in the WHO-hosted LimeSurvey data form and sent to focal points in the 55 countries and territories in the European Region between September and October 2023. The questions covered TPT, systematic screening and infection prevention and control.</p><p><strong>Results: </strong>A total of 28 questionnaires were returned, corresponding to an overall 51% response rate. Most national policies for TPT and TB screening are in line with the latest WHO guidelines. However, implementation of TB screening, prevention, and infection control activities is lagging. Results are presented separately for high-priority and low-priority countries.</p><p><strong>Conclusion: </strong>The survey identified several important areas that the PASS initiative will focus on to accelerate efforts towards reaching the targets set at the 2027 UN High-Level Meeting on TB for preventive therapy in the European Region. This will require a massive scale-up of efforts and larger investments, as well as coordinated approaches and interventions across the 'cascade' of prevention, from the identification of target populations to the completion of treatment.</p>","PeriodicalId":519984,"journal":{"name":"IJTLD open","volume":"1 8","pages":"349-354"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11308406/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJTLD open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5588/ijtldopen.24.0350","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: TB preventive treatment (TPT) is the primary available healthcare intervention to reduce the risk of progression from TB infection to TB disease. The WHO Regional Office for Europe established the European Prevention and Systematic Screening Initiative to End TB (PASS) to scale up activities related to the programmatic management of TPT. In the absence of a system to measure and monitor preventive activities, a baseline assessment survey was carried out to provide a reference to monitor the scale-up of the intervention.

Methods: This was a semi-structured survey including 52 questions that was developed, implemented in the WHO-hosted LimeSurvey data form and sent to focal points in the 55 countries and territories in the European Region between September and October 2023. The questions covered TPT, systematic screening and infection prevention and control.

Results: A total of 28 questionnaires were returned, corresponding to an overall 51% response rate. Most national policies for TPT and TB screening are in line with the latest WHO guidelines. However, implementation of TB screening, prevention, and infection control activities is lagging. Results are presented separately for high-priority and low-priority countries.

Conclusion: The survey identified several important areas that the PASS initiative will focus on to accelerate efforts towards reaching the targets set at the 2027 UN High-Level Meeting on TB for preventive therapy in the European Region. This will require a massive scale-up of efforts and larger investments, as well as coordinated approaches and interventions across the 'cascade' of prevention, from the identification of target populations to the completion of treatment.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
世界卫生组织欧洲地区的结核病预防活动。
背景:肺结核预防性治疗(TPT)是降低肺结核感染发展为肺结核病风险的主要可用医疗干预措施。世卫组织欧洲区域办事处制定了 "欧洲终结结核病预防和系统筛查倡议"(PASS),以扩大与结核病预防治疗计划管理相关的活动。由于缺乏衡量和监测预防活动的系统,因此开展了一项基线评估调查,为监测干预措施的推广情况提供参考:这是一项半结构式调查,包括 52 个问题,由世卫组织托管的 LimeSurvey 数据表格开发和实施,并于 2023 年 9 月至 10 月间发送给欧洲地区 55 个国家和地区的协调中心。这些问题涉及 TPT、系统筛查和感染预防与控制:结果:共收回 28 份问卷,总回复率为 51%。大多数国家的 TPT 和结核病筛查政策都符合世界卫生组织的最新指导方针。然而,结核病筛查、预防和感染控制活动的实施却相对滞后。高优先级国家和低优先级国家的结果分别列出:调查确定了 PASS 计划将重点关注的几个重要领域,以加快实现 2027 年联合国结核病高级别会议为欧洲地区预防性治疗设定的目标。这将需要大规模的努力和更多的投资,以及从确定目标人群到完成治疗的整个 "级联 "预防过程中的协调方法和干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Assessing the accuracy of the updated Fujifilm SILVAMP TB LAM II assay between lot numbers. Closing the gaps in childhood TB detection. Comparative efficacy of tetracyclines against isolates of Mycobacterium avium complex. Efficacy and safety data on pretomanid for drug-resistant TB. Ending the TB epidemic - what can we learn from the HIV epidemic?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1